Gemin X Pharmaceuticals Canada Inc.
Patent Owner
Stats
- 7 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Apr 16, 2013 most recent publication
Details
- 7 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 55 Total Citation Count
- May 28, 2004 Earliest Filing
- 2 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
8420693 Dipyrrole compounds, compositions, and methods for treating cancer or viral diseasesDec 22, 05Apr 16, 13[A61K]
8211912 Compositions and methods for effecting NAD+ levels using a nicotinamide phosphoribosyl tranferase inhibitorSep 25, 08Jul 03, 12[A61K]
8173677 levels using a nicotinamide phosphoribosyl transferase inhibitorMar 25, 09May 08, 12[A61K, A61P]
7491745 Pyrrole-Type compounds, compositions and methods for treating cancer or viral diseaseOct 16, 06Feb 17, 09[A61K]
7425553 Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseasesMay 28, 04Sep 16, 08[A61K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2008/0076,739 Methods for treating arthritis using triheterocyclic compoundsAbandonedAug 22, 07Mar 27, 08[A61K, A61P]
2008/0051,400 Methods for treating or preventing anemia or thrombocytopenia using a triheterocyclic compoundAbandonedJul 05, 07Feb 28, 08[A61K, A61P]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.